Medical Bionic Implants Market [Vision, Brain, Heart, Orthopedic & Ear] – Trends & Global Forecasts to 2017

Publisher Name :
Date:1-Dec-2012
No. of pages: 298
Inquire Before Buying

Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.

The global medical bionic implants market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The market for certain bionic devices such as exoskeletons, bionic orthopedics, and the bionic eye are skewed in favor of certain regions because of stronger research in these regions as compared to others. In this report, we are also focusing on bionic devices in pipeline, which include wearable artificial kidney, bio-lung, and artificial pancreas.

New and improved technologies, increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries leading to amputations, and rise in number of people awaiting organ transplants are the major drivers slated to propel the growth of this market. However, a few pivotal factors restraining the growth of this market are high cost of devices and uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development. The opportunities in this market for new entrants include improving income levels, and rising awareness in emerging economies.

North America dominates the medical bionic implants market in 2012, followed by Europe. However, the adoption of novel medical bionics as a therapy in emerging markets is gaining momentum at a fast pace due to a growing population and increasing awareness among patients and players. In addition, increasing healthcare expenditure, growing income levels, rising preference for bionics due to better and efficient recovery as compared to prosthetics, growing surgical procedures in lieu with medical tourism, and lesser competition than mature countries, have amplified the interest of market players in emerging markets.

The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).

Scope of the Report

This research report categorizes the global medical bionic implants market on the basis of products, technologies, and type of fixation. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Medical Bionics Market, By Products

  • Vision Bionics
  • Bionic Eye

Ear Bionics

  • Cochlear Implant
  • Bone Anchored Hearing Aid (Baha)

Orthopedic Bionics

  • Bionic Limb
  • Bionic Hand
  • Bionic Leg
  • Bionic Knee
  • Bionic Feet
  • Bionic Finger
  • Exoskeleton
  • Electrical Bone Growth Stimulators
  • Invasive Bone Growth Stimulators
  • Non-Invasive Bone Growth Stimulators

Heart Bionics

  • Pacemaker
  • Implantable Cardiac Pacemaker
  • External Pacemaker
  • Total Artificial Heart
  • Ventricular Assist Device
  • Artificial Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves

Neural /Brain Bionics

  • Deep Brain Stimulator
  • Vagus Nerve Stimulator
  • Spinal Cord Stimulator

Global Medical Bionics Market, By Technology

  • Mechanical
  • Electronic

Global Medical Bionics Market, By Method of Fixation

  • Implantable
  • Externally Worn

Medical Bionics Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Medical Bionic Implants Market [Vision, Brain, Heart, Orthopedic & Ear] – Trends & Global Forecasts to 2017

Table Of Contents

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 EVOLUTION
3.3 MARKET SEGMENTATION
3.4 BIONICS & PROSTHESES: SIMILARITIES & DIFFERENCES
3.5 MARKET DYNAMICS
3.5.1 DRIVERS
3.5.1.1 Technological advancements
3.5.1.2 Increasing organ failure owing to aging & age-related disorders
3.5.1.3 Increasing accidents & injuries leading to amputations
3.5.1.4 Rise in number of people awaiting organ transplants
3.5.2 RESTRAINTS
3.5.2.1 High cost of devices and uncertain reimbursement scenarios in different regions
3.5.2.2 Limited surgical expertise
3.5.2.3 High cost of development
3.5.3 OPPORTUNITIES
3.5.3.1 Advantageous in comparison prosthetics
3.5.3.2 Improving income levels & rising awareness could push demand in emerging economies
3.6 MARKET SHARE ANALYSIS
3.6.1 EAR BIONICS MARKET
3.6.2 ORTHOPEDIC BIONICS MARKET
3.6.3 HEART BIONICS MARKET
3.6.4 BRAIN/NEURAL BIONICS MARKET
3.7 EMERGING TECHNOLOGIES
3.7.1 BIONICS IN THE PIPELINE
3.7.1.1 Artificial Pancreas
3.7.1.2 Bio-Lung
3.7.1.3 Wearable Artificial Kidney

4 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 VISION BIONICS
4.2.1 BIONIC EYE
4.3 EAR BIONICS
4.3.1 COCHLEAR IMPLANT
4.3.2 BONE ANCHORED HEARING AID (BAHA)
4.4 ORTHOPEDIC BIONICS
4.4.1 BIONIC LIMB
4.4.1.1 Bionic Hand
4.4.1.2 Bionic Leg
4.4.1.2.1 Bionic Knee
4.4.1.2.2 Bionic Feet
4.4.2 BIONIC FINGER
4.4.3 EXOSKELETON
4.4.4 ELECTRICAL BONE GROWTH STIMULATORS
4.4.4.1 Invasive Bone Growth Stimulators
4.4.4.2 Non-invasive Bone Growth Stimulators
4.5 HEART BIONICS
4.5.1 PACEMAKER
4.5.1.1 Implantable Cardiac Pacemaker
4.5.1.2 External Pacemaker
4.5.2 TOTAL ARTIFICIAL HEART
4.5.3 VENTRICULAR ASSIST DEVICE
4.5.4 ARTIFICIAL HEART VALVE
4.5.4.1 Mechanical Heart Valve
4.5.4.2 Tissue Heart Valve
4.6 NEURAL/BRAIN BIONICS
4.6.1.1 Deep Brain Stimulator
4.6.1.2 Vagus Nerve Stimulator
4.6.1.3 Spinal Cord Stimulator

5 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 ELECTRONIC BIONICS
5.3 MECHANICAL

6 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TYPE OF FIXATION
6.1 INTRODUCTION
6.2 EXTERNALLY WORN
6.3 IMPLANTABLE

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA- PACIFIC
7.5 ROW

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
8.4 NEW PRODUCT LAUNCH
8.5 APPROVALS
8.6 EXPANSION
8.7 OTHER DEVELOPMENTS

9 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 ABIOMED, INC.
9.2 BERLIN HEART GMBH
9.3 BIOMET, INC.
9.4 BOSTON SCIENTIFIC CORPORATION
9.5 COCHLEAR, LTD.
9.6 EDWARDS LIFESCIENCES CORPORATION
9.7 EKSO BIONICS
9.8 HEARTWARE INTERNATIONAL, INC.
9.9 IWALK, INC.
9.10 JARVIK HEART, INC.
9.11 LIFENET HEALTH
9.12 MED-EL ELEKTROMEDIZINISCHE GERÄTE G.M.B.H.
9.13 MEDTRONIC, INC.
9.14 NANO RETINA, INC.
9.15 ORTHOFIX INTERNATIONAL N.V.
9.16 OSSUR
9.17 OTTO BOCK HEALTHCARE GMBH.
9.18 SECOND SIGHT MEDICAL PRODUCTS, INC.
9.19 SONOVA HOLDING AG
9.20 ST. JUDE MEDICAL, INC.
9.21 SORIN S.P.A.
9.22 TERUMO CORPORATION
9.23 THORATEC CORPORATION
9.24 TIBION CORPORATION
9.25 TOUCH BIONICS, LTD.

List Of Tables

TABLE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 2 MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 3 VISION BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 4 GLOBAL EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 5 EAR BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 6 COCHLEAR IMPLANT MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 7 BONE ANCHORED HEARING AID (BAHA) MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 8 GLOBAL ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 9 ORTHOPEDIC BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 GLOBAL BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 11 BIONIC LIMB MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 12 BIONIC HAND MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 GLOBAL BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 14 BIONIC LEG MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 15 BIONIC KNEE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 16 BIONIC FEET MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 17 BIONIC FINGER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 18 EXOSKELETON MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 19 GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY PRODUCTS, 2010 – 2012 ($MILLION)
TABLE 20 ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 21 INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 22 NON INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 23 GLOBAL HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 24 HEART BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 25 GLOBAL PACEMAKER MARKET REVENUE, BY PRODUCTS, 2010 – 2012 ($MILLION)
TABLE 26 PACEMAKER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 27 TOTAL ARTIFICIAL HEART MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 28 VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 29 GLOBAL ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCT TYPE, 2010 – 2017 ($MILLION)
TABLE 30 ARTIFICIAL HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 31 MECHANICAL HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 32 TISSUE HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 33 GLOBAL NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 34 NEURAL/BRAIN BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 35 DEEP BRAIN STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 36 VAGUS NERVE STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 37 SPINAL CORD STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 38 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION)
TABLE 39 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY TYPE OF FIXATION, 2010 – 2017 ($MILLION)
TABLE 40 NORTH AMERICA: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 41 NORTH AMERICA: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 42 NORTH AMERICA: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 43 NORTH AMERICA: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 44 NORTH AMERICA: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 45 NORTH AMERICA: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 46 NORTH AMERICA: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 47 NORTH AMERICA: ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)
TABLE 49 EUROPE: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 50 EUROPE: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 51 EUROPE: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 52 EUROPE: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 53 EUROPE: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 54 EUROPE: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 55 EUROPE: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 EUROPE: ARTIFICAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 57 EUROPE: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)
TABLE 58 ASIA-PACIFIC: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 59 ASIA-PACIFIC: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 60 ASIA-PACIFIC: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 61 ASIA-PACIFIC: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 62 ASIA-PACIFIC: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 63 ASIA-PACIFIC: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 66 ASIA-PACIFIC: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 67 ROW: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 68 ROW: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 69 ROW: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 70 ROW: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 71 ROW: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 72 ROW: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 ROW: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 74 ROW: ARTIFICAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 75 ROW: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 76 MERGERS & ACQUISITIONS, 2010 –2012
TABLE 77 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, 2010 –2012
TABLE 78 NEW PRODUCT LAUNCH, 2010 –2012
TABLE 79 APPROVALS, 2010 –2012
TABLE 80 EXPANSION, 2010 – 2012
TABLE 81 OTHER DEVELOPMENTS, 2010 – 2012
TABLE 82 ABIOMED, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 83 ABIOMED, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 84 ABIOMED, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 85 BIOMET, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 86 BIOMET, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 87 BIOMET, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 88 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 89 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 90 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 91 COCHLEAR, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 92 COCHLEAR, LTD.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 93 COCHLEAR, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 94 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE 2009 – 2011 ($MILLION)
TABLE 95 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 96 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 97 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 98 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 99 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 100 MEDTRONIC, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2012 ($MILLION)
TABLE 101 MEDTRONIC, INC.: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 102 MEDTRONIC, INC.: RESTORATIVE THERAPIES GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 103 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 104 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 105 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 106 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 107 OSSUR HF: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 108 OSSUR HF: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 109 OSSUR HF: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 110 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, 2009 – 2011 ($MILLION)
TABLE 111 OTTO BOCK HEALTHCARE GMBH. TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 112 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 113 SONOVA HOLDING AG: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 114 SONOVA HOLDING AG: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 115 SONOVA HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 116 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 117 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 118 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 119 SORIN S.P.A.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 120 SORIN S.P.A.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 121 SORIN S.P.A.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 122 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 123 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 125 THORATEC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 126 THORATEC CORPORATION: TOTAL REVENUE, BY PRODUCTS LINES, 2009 – 2011 ($MILLION)
TABLE 127 THORATEC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)

List Of Figures

FIGURE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
FIGURE 2 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY SEGMENTS
FIGURE 3 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS
FIGURE 4 MEDICAL BIONIC IMPLANTS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 5 EAR BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 6 ORTHOPEDIC BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 7 HEART BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 8 BRAIN/NEURAL BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 9 CLASSIFICATION OF ORTHOPEDIC BIONICS
FIGURE 10 CLASSIFICATION OF BIONIC LIMBS
FIGURE 11 CLASSIFICATION OF ELECTRICAL BONE GROWTH STIMULATORS
FIGURE 12 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TECHNOLOGY
FIGURE 13 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TYPE OF FIXATION
FIGURE 14 KEY GROWTH STRATEGIES, 2010 – 2012

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • Wright Medical: Organization, Technologies, Products, Marketing, R&D, Strategies
    Published: 28-Jul-2014        Price: US $1850 Onwards        Pages: 30
    A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.......
  • UK Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
    Published: 28-Jul-2014        Price: US $4350 Onwards        Pages: 615
    This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Report HighlightsBusiness and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • Stryker: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
    Published: 27-Jul-2014        Price: US $1850 Onwards        Pages: 35
    A strategic assessment of Stryker, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.......
  • Spain Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
    Published: 27-Jul-2014        Price: US $4350 Onwards        Pages: 610
    This new study from Venture Planning Group contains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Report HighlightsBusiness and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • 2014 Deep Research Report on Global and China Chitosan Industry
    Published: 26-Jul-2014        Price: US $2200 Onwards        Pages: 211
    This is a professional and depth research report on Global and China Chitosan Industry. The report firstly introduced Chitosan basic information included Chitosan definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Chitosan Industry policy and plan, Chitosan product specification, manufacturing process, product cost structure etc. t......
  • Smith & Nephew: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
    Published: 26-Jul-2014        Price: US $1850 Onwards        Pages: 37
    A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.......
  • Japan Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
    Published: 26-Jul-2014        Price: US $5400 Onwards        Pages: 620
    This new study from Venture Planning Group contains 620 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Report HighlightsBusiness and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition)
    Published: 25-Jul-2014        Price: US $1495 Onwards        Pages: 191
    China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas and multinat......
  • Label-Free Binding Analysis Trends 2014
    Published: 25-Jul-2014        Price: US $2500 Onwards        Pages: 50
    Executive SummaryThis market report summarizes the results of HTStec’s 4th global web-based benchmarking survey on label-free (LF) binding analysis carried out in July 2014. The study was initiated by HTStec as part of its regular (every 2 years) tracking of this life science marketplace. The questionnaire was compiled to address the needs and interests of the LF binding analysis vendor community. The main objectives were to comprehensively document current experience of and future in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs